MeiraGTx Holdings plc (MGTX)
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
$339.31M
Dr. Alexandria Forbes
361.00
New York, NY
Jun 08, 2018
-3.09
$-1.42
2.13
2.36
-1,146.81%
-2.95
-0.25
3.43
40.69
2.36
-34.93%
-86.28%
Similar stocks (15)
Rhythm Pharmaceuticals, Inc.
RYTM
IDEAYA Biosciences, Inc.
IDYA
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Rocket Pharmaceuticals, Inc.
RCKT
AnaptysBio, Inc.
ANAB
Erasca, Inc.
ERAS
Nuvation Bio Inc.
NUVB
C4 Therapeutics, Inc.
CCCC
Solid Biosciences Inc.
SLDB
Generation Bio Co.
GBIO
Acumen Pharmaceuticals, Inc.
ABOS
Eton Pharmaceuticals, Inc.
ETON
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
ETF Exposure (20)
iShares Micro-Cap ETF
IWC
0.04118%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.025%
iShares Biotechnology ETF
IBB
0.01738%
SPDR S&P International Small Cap ETF
GWX
0.010866%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00795%
ProShares Ultra Nasdaq Biotechnology
BIB
0.007270061258660138%
iShares Russell 2000 ETF
IWM
0.00578%
Dimensional U.S. Small Cap ETF
DFAS
0.0040304%
iShares Russell 2000 Value ETF
IWN
0.00386%
ProShares Ultra Russell2000
UWM
0.002252428620864153%
ProShares UltraPro Russell2000
URTY
0.0011100940576718472%
ProShares Hedge Replication ETF
HDG
9.429615944926217e-4%
iShares Russell 3000 ETF
IWV
4.7e-4%
Dimensional U.S. Equity ETF
DFUS
1.5366000000000002e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.2626e-4%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Similar stocks (15)
Rhythm Pharmaceuticals, Inc.
RYTM
IDEAYA Biosciences, Inc.
IDYA
Edgewise Therapeutics, Inc.
EWTX
Keros Therapeutics, Inc.
KROS
Rocket Pharmaceuticals, Inc.
RCKT
AnaptysBio, Inc.
ANAB
Erasca, Inc.
ERAS
Nuvation Bio Inc.
NUVB
C4 Therapeutics, Inc.
CCCC
Solid Biosciences Inc.
SLDB
Generation Bio Co.
GBIO
Acumen Pharmaceuticals, Inc.
ABOS
Eton Pharmaceuticals, Inc.
ETON
Eledon Pharmaceuticals, Inc.
ELDN
Kronos Bio, Inc.
KRON
ETF Exposure (20)
iShares Micro-Cap ETF
IWC
0.04118%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.025%
iShares Biotechnology ETF
IBB
0.01738%
SPDR S&P International Small Cap ETF
GWX
0.010866%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00795%
ProShares Ultra Nasdaq Biotechnology
BIB
0.007270061258660138%
iShares Russell 2000 ETF
IWM
0.00578%
Dimensional U.S. Small Cap ETF
DFAS
0.0040304%
iShares Russell 2000 Value ETF
IWN
0.00386%
ProShares Ultra Russell2000
UWM
0.002252428620864153%
ProShares UltraPro Russell2000
URTY
0.0011100940576718472%
ProShares Hedge Replication ETF
HDG
9.429615944926217e-4%
iShares Russell 3000 ETF
IWV
4.7e-4%
Dimensional U.S. Equity ETF
DFUS
1.5366000000000002e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.2626e-4%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%